Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details Textual)

v2.4.0.6
Commitments and Contingencies (Details Textual) (USD $)
0 Months Ended 3 Months Ended 92 Months Ended 3 Months Ended
Feb. 05, 2012
Oct. 01, 2011
Jan. 05, 2011
Oct. 01, 2010
Mar. 05, 2009
Nov. 10, 2008
Sep. 29, 2008
Sep. 19, 2008
Jun. 29, 2007
Jul. 06, 2006
Mar. 31, 2013
Sep. 21, 2012
Jun. 01, 2012
Sep. 30, 2009
Aug. 31, 2009
Mar. 22, 2006
Mar. 31, 2013
Subsequent Event [Member]
Mar. 31, 2013
Agreement With Theradex Systems [Member]
Mar. 31, 2012
Agreement With Theradex Systems [Member]
Mar. 31, 2013
Agreement With Theradex Systems [Member]
Mar. 31, 2013
Agreements With Ash Stevens [Member]
Mar. 31, 2013
Master Laboratory Services Agreement With Wil Research Laboratories [Member]
May 21, 2012
Consulting Arrangements [Member]
Feb. 18, 2011
Consulting Arrangements [Member]
Apr. 07, 2010
Consulting Arrangements [Member]
Cooperative Research and Development Project Commitments, Amount                         $ 50,000 $ 200,000 $ 100,000 $ 200,000                  
Cooperative Research Commitments Due, Current                               200,000                  
Payments To Fund Cooperative Research and Development 25,000 25,000 50,000 50,000 50,000   50,000   200,000 200,000                              
National Institute Of Health Patent License Agreement, Terms               The PLA provided for an initial payment of $25,000 to the NIH within 60 days of September 19, 2008, and for a minimum annual royalty of $30,000 on January 1 of each calendar year following the year in which the CRADA is terminated.                                  
Patent License Agreement, Minimum Annual Royalty, Amount                                 30,000                
Payments To National Institute Of Health Patent License Agreement Initial Payment           25,000                                      
Research and Development Contract, Estimated Cost, Various Clinical Studies                                         62,000 99,000      
Research and Development Contract, Payments For Various Clinical Studies                                         58,935 58,500      
Principal Cash Obligations and Commitments, Current                     195,253                            
Annual Fee Payable, Clinical Trial                       2,000,000                     25,000 25,000 25,000
Fees For Services Total                                   7,393 54,187 186,980          
Clinical Cost Charged To Operations Total                                   $ 48,783